A judge has dismissed a proposed class action brought against Bausch & Lomb Inc. over its contact lens solution, saying the complaint failed to reach the pleading standards established in the U.S. Supreme Court's Twombly ruling.
The underwriters of an initial public offering of Isolagen Inc. stock have asked a judge to reconsider a previous decision to not dismiss them from a proposed securities class action lawsuit.
Five months after certifying a class that alleges Comcast Corp. stifled competition in Philadelphia's cable subscription market, a federal judge has certified a class in Chicago bringing similar allegations.
Amid widespread criticism, the U.S. Department of Justice has voiced its intention to expand a year-long investigation into the suspicious billing practices of L. Tersigni Consulting PC in numerous asbestos-related bankruptcies.
Medical device maker Stryker Corp. has filed a scathing attack against competitor Synthes Corp. for trying to stay a lawsuit involving patents for a clamp used in trauma surgery.
Continuing its battle against the U.S. government's claims that it inflated prices to scam Medicare and boost sales, Abbott Laboratories Inc. is fighting a bid by prosecutors to depose the company's recently retired president and chief operating officer.
Three Philadelphia-based funeral directors sold hundreds of cadavers to a former oral surgeon and nurse, who then dismembered them in unsanitary conditions and resold the diseased body parts for use in transplants, a grand jury charged on Thursday.
The economic impact of the second-largest beef recall in U.S. history involving more than 21.7 million pounds of ground beef products has forced Topps Meat Co. LLC to go out of business, effective immediately, the company said Friday.
Attorneys accused of purposely delaying and disrupting a long-running lawsuit against a group of health insurers have promised to appeal a district court judge's order that they pay a $5 million penalty for what the judge deemed evasive and unethical behavior.
Wal-Mart Inc. will have to cough up an additional $62.3 million in liquidated damages to workers who won $78.5 million from the retailer in October 2006, in a lawsuit where a class of more than 100,000 plaintiffs alleged that they were not paid for all the time they worked.
The U.S. Federal Trade Commission has given the green light to pharmaceutical company Mylan Laboratories' $6.6 billion acquisition of generic-drug maker E. Merck OHG, but the commission forced the companies to sell five generic drugs they currently produce due to competition concerns.
Class action firm Milberg Weiss has announced a proposed $15 million deal with PMA Capital Corp. and its underwriters to settle a shareholder suit connected to the company's three public offerings.
A federal appeals court has granted Thomson Financial LLC’s request for a stay of a district court’s permanent injunction on the operation and service of its electronic bid submission software pending the outcome of the appeal.
A federal judge has granted class status to thousands of current and previous airplane owners who claim Lycoming Engines designed and built defective engine crankshafts that can cause a total loss of engine power as well as in-flight engine failures.
Adams Respiratory Therapeutics Inc. on Thursday filed suit against Perrigo Co., claiming the generic maker’s abbreviated new drug application for a generic version of Mucinex infringes its patent for the drug.
Verizon Information Systems Inc. employees who sued the company for allegedly making illegal deductions from their wages and failing to pay overtime continue to fight for a final judgment that would let them immediately appeal the claim on deductions.
A proposed class action lawsuit alleging securities fraud on the part of biotechnology company Isolagen Inc. and 11 current and former directors will move forward with all claims intact, a judge ruled Wednesday.
A Pennsylvania state court has chucked a woman's lawsuit against Wyeth, Pfizer Inc. and Upjohn Co. over their controversial hormone replacement therapies, finding that she missed the two-year deadline to lodge her complaint.
Montana wants its suit over Zyprexa, the antipsychotic whose alleged dangers have led maker Eli Lilly & Co. to shell out billions to plaintiffs, separated from the consolidated federal action and sent back to state court.
The U.S. Equal Employment Opportunity Commission has launched a Title VII discrimination suit against Circuit City Stores Inc., claiming that a class of male employees was subjected to unwelcome sexual advances by a male store director.